MicroSert

Intraocular Implant for Sustained Drug Release

Health Tech & Life Sciences
Non Active, Dec 2025 ceased to operate
Seed Nesher, Israel Founded 2010
LinkedIn
Last updated 2026-06-18
Total raised
$806K
Last: Grant 2019-11
Stage
Seed
Founded
2010
Headcount
3
HQ
Nesher, Israel
Sector
Health Tech & Life Sciences

About

MicroSert develops an easily implantable, refillable, reservoir-type device for long-lasting ocular drug release. The device is capable of sustained and controlled release of biologic medications and can be refilled for up to two years after being implanted. MicroSert intends to further develop this versatile drug-delivery platform for the treatment of age-related macular degeneration and diabetic macular edema.

The MicroSert implant is made of medical-grade elastomeric polymers. The implant is inserted into the eye in an empty compressed phase using a fine needle, with no incision needed. By filling the implant with medication and removing the needle, the implant remains anchored beneath the conjunctiva, and the drug is released in a controlled and sustained manner. Insertion of the implant is performed using a unique insertion device in a one-step, outpatient procedure.

Funding history · 2 rounds · $806K total

2019-11
Grant $56K
2012-01

Q&A

What is MicroSert's primary product or technology?
MicroSert develops an intraocular implant for sustained drug release, designed as an easily implantable, refillable, reservoir-type device for long-lasting ocular drug delivery. It is intended for conditions like age-related macular degeneration and diabetic macular edema.
What is the current status of MicroSert?
MicroSert is currently inactive, having ceased to operate in December 2025.
When was MicroSert founded?
MicroSert was founded in July 2010.
How many employees does MicroSert have?
MicroSert has an employee count in the 1-10 range.
What is MicroSert's total funding to date?
MicroSert has raised a total of $806,000 USD.
Who was an investor in MicroSert's 2012 funding round?
Mayan Ventures invested in MicroSert's funding round in January 2012.
What was MicroSert's most recent funding event?
MicroSert received a Grant in November 2019 from EU Horizon 2020, amounting to $56,000 USD.
Who is the Founder & CEO of MicroSert?
Avraham Shekalim is the Founder & CEO of MicroSert.

Team · 1

Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcarePatientsProvidersMedical Devices Industry
Business model
B2B

Highlights

1 Patents

Tags

eye-diseasesmedical-devicesophthalmologydrug-deliverysustained-releasemedical-technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

LinkedInlinkedin.com/company/18613602

Identifiers & details

Founded2010-7
Employees (exact)3
Status reasonNon Active, Dec 2025 ceased to operate